CN109985070A - A kind of Cicada flower extract and its application in the preparation of antioxidant medicine - Google Patents
A kind of Cicada flower extract and its application in the preparation of antioxidant medicine Download PDFInfo
- Publication number
- CN109985070A CN109985070A CN201910328312.8A CN201910328312A CN109985070A CN 109985070 A CN109985070 A CN 109985070A CN 201910328312 A CN201910328312 A CN 201910328312A CN 109985070 A CN109985070 A CN 109985070A
- Authority
- CN
- China
- Prior art keywords
- polysaccharide
- cicada flower
- cicada
- ethanol
- flower
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000931705 Cicada Species 0.000 title claims abstract description 99
- 239000000284 extract Substances 0.000 title claims abstract description 24
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 22
- 239000003963 antioxidant agent Substances 0.000 title claims abstract description 11
- 239000003814 drug Substances 0.000 title claims abstract description 10
- 238000002360 preparation method Methods 0.000 title claims description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 96
- 150000004676 glycans Chemical class 0.000 claims abstract description 88
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 81
- 239000005017 polysaccharide Substances 0.000 claims abstract description 81
- 238000001556 precipitation Methods 0.000 claims abstract description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 18
- 238000000034 method Methods 0.000 claims abstract description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 12
- 238000005238 degreasing Methods 0.000 claims description 11
- 238000000605 extraction Methods 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 11
- 239000000047 product Substances 0.000 claims description 10
- 244000184734 Pyrus japonica Species 0.000 claims description 9
- 239000006228 supernatant Substances 0.000 claims description 9
- 239000012153 distilled water Substances 0.000 claims description 7
- 239000003208 petroleum Substances 0.000 claims description 7
- 239000006187 pill Substances 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- 102000011759 adducin Human genes 0.000 claims description 4
- 108010076723 adducin Proteins 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 4
- 239000000287 crude extract Substances 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- 150000003333 secondary alcohols Chemical class 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 2
- 239000006196 drop Substances 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims description 2
- 238000002390 rotary evaporation Methods 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 238000007654 immersion Methods 0.000 claims 1
- 238000005516 engineering process Methods 0.000 abstract description 3
- 230000003064 anti-oxidating effect Effects 0.000 abstract description 2
- 239000012535 impurity Substances 0.000 abstract description 2
- 102000004169 proteins and genes Human genes 0.000 abstract description 2
- 108090000623 proteins and genes Proteins 0.000 abstract description 2
- 235000019441 ethanol Nutrition 0.000 abstract 3
- 239000000470 constituent Substances 0.000 abstract 1
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 40
- 230000000694 effects Effects 0.000 description 22
- 241000255925 Diptera Species 0.000 description 14
- 239000002609 medium Substances 0.000 description 14
- 230000032683 aging Effects 0.000 description 10
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 7
- 241000255588 Tephritidae Species 0.000 description 7
- 235000006708 antioxidants Nutrition 0.000 description 7
- 229940118019 malondialdehyde Drugs 0.000 description 7
- 102000016938 Catalase Human genes 0.000 description 5
- 108010053835 Catalase Proteins 0.000 description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 5
- 230000004083 survival effect Effects 0.000 description 5
- 241001248610 Ophiocordyceps sinensis Species 0.000 description 4
- 239000007640 basal medium Substances 0.000 description 4
- 230000036542 oxidative stress Effects 0.000 description 4
- 241001625026 Cordyceps cicadae Species 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 239000012223 aqueous fraction Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 239000011344 liquid material Substances 0.000 description 3
- 150000004804 polysaccharides Polymers 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 238000004064 recycling Methods 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- -1 CP4 polysaccharide Chemical class 0.000 description 2
- 108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 2
- 241000190633 Cordyceps Species 0.000 description 2
- 102000006587 Glutathione peroxidase Human genes 0.000 description 2
- 108700016172 Glutathione peroxidases Proteins 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 208000020832 chronic kidney disease Diseases 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 235000003642 hunger Nutrition 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 238000001325 log-rank test Methods 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000037351 starvation Effects 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 241000254137 Cicadidae Species 0.000 description 1
- 241000221751 Claviceps purpurea Species 0.000 description 1
- 206010011469 Crying Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001599018 Melanogaster Species 0.000 description 1
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical group CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 1
- 229910052956 cinnabar Inorganic materials 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000012050 conventional carrier Substances 0.000 description 1
- 239000006783 corn meal agar Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 230000032669 eclosion Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- AZHSSKPUVBVXLK-UHFFFAOYSA-N ethane-1,1-diol Chemical compound CC(O)O AZHSSKPUVBVXLK-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 239000003228 hemolysin Substances 0.000 description 1
- 230000003832 immune regulation Effects 0.000 description 1
- 238000010874 in vitro model Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000000324 neuroprotective effect Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 238000003359 percent control normalization Methods 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 229940057838 polyethylene glycol 4000 Drugs 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000007348 radical reaction Methods 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 239000002683 reaction inhibitor Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Insects & Arthropods (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Animal Husbandry (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
技术领域technical field
本发明属于医药技术领域,具体涉及从中药材金蝉花中制备具有抗氧化活性的部位及在制备抗氧化药物方面的应用。The invention belongs to the technical field of medicine, and specifically relates to the preparation of a part with antioxidative activity from the Chinese medicinal material Cicada japonica and the application in the preparation of antioxidative drugs.
背景技术Background technique
抗氧化是抗氧化自由基的简称,研究表明,癌症、衰老或其它疾病大都与过量自由基的产生有关联,随着世界范围内人口老龄化问题的凸显,以及人们对健康长寿的日益追求,寻找天然、高效的抗氧化剂是现代医药和保健品的发展趋势。Antioxidant is the abbreviation of antioxidant free radicals. Studies have shown that cancer, aging or other diseases are mostly related to the production of excess free radicals. Looking for natural and efficient antioxidants is the development trend of modern medicine and health care products.
金蝉花(Cordyceps cicadae)是麦角菌科真菌大蝉草寄生在蝉若虫后形成的干燥复合体,是一种药食两用真菌,与冬虫夏草的无性型同属,是我国传统名贵中药材之一。蝉花之名最早见于《雷公炮炙论》,是第一个作为药用的虫草属真菌,《证类本草》首载蝉花具有“味甘、寒,无毒。主小儿天吊,惊痫,夜啼心悸……医工云入药最奇”之功效。现代研究表明,金蝉花具有免疫调节、抗氧化衰老、镇静安眠、缓解痛风、补肾强肾、抗肿瘤、抗疲劳及应激、调节脂质代谢等功效;临床上,金蝉花治疗慢性肾病效果显著。其活性成分主要包括多糖、核苷、甘露醇、麦角甾醇等,且研究表明,蝉花的虫草酸含量约为冬虫夏草的2.2倍,腺苷约是其4倍,虫草多糖的含量与之接近,总氨基酸含量是其2倍多,维生素E、叶酸、核黄素、B族维生素等均高于冬虫夏草,重金属含量远低于冬虫夏草。陈以平教授等对金蝉花的临床研究发现,其在保护肾功能、延缓慢性肾功能衰竭方面功效显著;宋捷民等发现蝉花可显著提高血清溶血素水平和巨噬细胞的吞噬活性,表明其具有促进免疫功能的作用;多项药理学研究表明金蝉花多糖是一种良好的自由基清除剂或自由基反应抑制剂,可通过提高生物的造血功能和免疫功能而达到其抗氧化和抗衰老作用。因此,通过对金蝉花活性部位的提取分析,有望开发出具有高效抗氧化活性的新型药物。Cordyceps cicadae (Cordyceps cicadae) is a dry complex formed by the ergot fungus Cordyceps cicadae parasitized after cicada nymphs. . The name of cicada flower was first seen in "Leigong Paozhi Lun", which is the first Cordyceps fungus used as a medicinal. Epilepsy, night crying and heart palpitations... The most amazing effect of medical workers' cloud-based medicine. Modern research shows that Cicada flower has the functions of immune regulation, anti-oxidative aging, sedative and sleeping, relieving gout, invigorating kidney and strengthening kidney, anti-tumor, anti-fatigue and stress, regulating lipid metabolism, etc. Clinically, Cicada flower is used to treat chronic kidney disease. The effect is remarkable. Its active ingredients mainly include polysaccharides, nucleosides, mannitol, ergosterol, etc., and studies have shown that the content of Cordyceps acid in cicadas is about 2.2 times that of Cordyceps sinensis, and the content of adenosine is about 4 times that of Cordyceps sinensis. The total amino acid content is more than twice that of it, vitamin E, folic acid, riboflavin, and B vitamins are all higher than those of Cordyceps sinensis, and the content of heavy metals is much lower than that of Cordyceps sinensis. The clinical study of Cicada by Professor Chen Yiping and others found that it has a significant effect in protecting renal function and delaying chronic renal failure; Song Jiemin and others found that Cicada can significantly increase the level of serum hemolysin and the phagocytic activity of macrophages, indicating that it has The role of promoting immune function; a number of pharmacological studies have shown that cinnabar polysaccharide is a good free radical scavenger or free radical reaction inhibitor, which can achieve its anti-oxidation and anti-aging by improving the hematopoietic function and immune function of organisms effect. Therefore, through the extraction and analysis of the active parts of Cicada flower, it is expected to develop new drugs with high-efficiency antioxidant activity.
现代技术对金蝉花活性物质的研究主要集中在金蝉花某一整体活性部位的提取,如专利CN201410046301.8及专利CN201410046249.6分别对金蝉花醇提物的石油醚部位、乙酸乙酯部位,专利CN201410046280.X对金蝉花水提取物的正丁醇部位,专利CN201410232441.4对金蝉花水提物的醇沉粗多糖等活性物质进行提取,并研究其神经保护和抗衰老活性,但以上发明对金蝉花活性部位分离精细化程度不够,多糖有效利用率不高。The research on the active substances of Cicada flower by modern technology mainly focuses on the extraction of a certain overall active part of Cicada flower. Part, patent CN201410046280.X is for the n-butanol part of the water extract of Cicada flower, patent CN201410232441.4 extracts active substances such as alcohol precipitation crude polysaccharide of the water extract of Cicada flower, and studies its neuroprotective and anti-aging activities However, the above invention is not enough for the separation and refinement of the active parts of Cicada flower, and the effective utilization rate of polysaccharides is not high.
发明内容SUMMARY OF THE INVENTION
本发明所要解决的关键技术问题是利用金蝉花不同多糖组分对乙醇醇沉浓度不同的性质,使多糖分级分离纯化,提供了一种有效提取金蝉花多糖组分的方法,为寻找具有精准抗氧化活性的金蝉花活性成分提供来源。The key technical problem to be solved by the present invention is to utilize the different properties of different polysaccharide components of Cicada chinensis to ethanol alcohol precipitation, so as to fractionate and purify the polysaccharide, and provide a method for effectively extracting the polysaccharide components of Cicada chinensis. Provides the source of the precise antioxidant activity of Cicada flower active ingredients.
本发明的第一个方面涉及一种金蝉花多糖提取物及其制备方法,该提取物纯度较高且具有高效抗氧化活性。本发明的技术方案如下:一种金蝉花多糖提取物的制备方法,按照下述步骤进行:The first aspect of the present invention relates to a polysaccharide extract of Cicada flower and a preparation method thereof. The extract has high purity and high antioxidant activity. The technical scheme of the present invention is as follows: a preparation method of the polysaccharide extract of Cicada flower is carried out according to the following steps:
步骤1)对金蝉花药材进行脱脂;Step 1) degreasing the Cicada flower medicinal material;
步骤2)将脱脂后的金蝉花药材,加入蒸馏水回流提取,减压浓缩得到金蝉花多糖粗提液。Step 2) Add the degreasing Cicada flower medicinal material, add distilled water for reflux extraction, and concentrate under reduced pressure to obtain a crude extract of Cicada flower polysaccharide.
步骤3)对步骤2)中金蝉花多糖粗提液加入95%乙醇,使乙醇最终质量浓度达到30-40%于低温条件下静置醇沉数小时后,对所得沉淀去除残留乙醇后冷冻干燥,得到一级醇沉产物CP1和一级上清液CS1。Step 3) Add 95% ethanol to the crude extract of Cicada flower polysaccharide in step 2), so that the final mass concentration of ethanol reaches 30-40%, and after standing for several hours under low temperature conditions for alcohol precipitation, the obtained precipitation is freed from residual ethanol and then frozen. After drying, the primary alcohol precipitation product CP1 and the primary supernatant CS1 are obtained.
步骤4)将步骤3)所得一级上清液CS1中加入95%乙醇,使乙醇最终质量达到40-50%(体积浓度),重复步骤3)操作,得到二级醇沉产物CP2和二级上清液CS2。Step 4) Add 95% ethanol to the first-level supernatant CS1 obtained in step 3), so that the final quality of ethanol reaches 40-50% (volume concentration), and repeat the operation of step 3) to obtain the secondary alcohol precipitation product CP2 and secondary alcohol precipitation products. Supernatant CS2.
步骤5)重复步骤4),依次使溶液乙醇最终质量浓度达到50%-60%(体积浓度),60%-70%(体积浓度),70%-80%(体积浓度),分别得到金蝉花醇沉产物CP3,CP4,CP5。Step 5) Repeat step 4), successively make the final mass concentration of solution ethanol reach 50%-60% (volume concentration), 60%-70% (volume concentration), 70%-80% (volume concentration), and obtain the golden cicada respectively. The anthocyanidin precipitation products CP3, CP4, CP5.
所述步骤1)所述脱脂是:干燥金蝉花药材,粉碎过药典2号筛,石油醚浸提金蝉花粉末,进行脱脂处理,烘干备用。优选地,金蝉花与石油醚的料液比为1:(8~3)。In the step 1), the degreasing is: drying the medicinal material of Cicada flower, pulverizing it through a No. 2 sieve in the pharmacopoeia, leaching the powder of Cicada flower with petroleum ether, carrying out degreasing treatment, and drying for subsequent use. Preferably, the solid-liquid ratio of Cicada flower to petroleum ether is 1:(8-3).
所述步骤2)中回流提取条件中金蝉花与蒸馏水的质量比为1:10~15,提取时间为2~3小时,提取温度为80~100℃,提取次数为2~4次,减压浓缩至原体积的1/10-1/5。In the reflux extraction condition in the step 2), the mass ratio of Cicada flower to distilled water is 1:10~15, the extraction time is 2~3 hours, the extraction temperature is 80~100 ℃, the extraction times is 2~4 times, and the extraction time is 2~4 times. Concentrate to 1/10-1/5 of the original volume.
所述步骤3)中低温条件为0℃-10℃,静置醇沉时间为12~48小时。The low temperature conditions in the step 3) are 0°C-10°C, and the time for standing alcohol precipitation is 12-48 hours.
所述步骤3)中沉淀去除残留乙醇的方法为将沉淀加水复溶,减压旋蒸去除乙醇溶剂,至溶液无明显乙醇气味。The method for removing residual ethanol by precipitation in the step 3) is to add water to reconstitute the precipitation, and then remove the ethanol solvent by rotary evaporation under reduced pressure until the solution has no obvious ethanol odor.
2、本发明第二个方面涉及对所述分级醇沉金蝉花多糖的用途,用于制备抗氧化药物。2. The second aspect of the present invention relates to the use of the graded alcohol-precipitated Cicada flower polysaccharide for the preparation of antioxidant drugs.
为了检测发明所得的醇沉金蝉花多糖产物的抗氧化活性,将本发明所得的各分级多糖按照1%(w/v)的比例添加到果蝇基础培养基中,饲喂生理性衰老果蝇和双氧水氧化应激果蝇,分别观察样品在不同剂量下对果蝇寿命的影响,并分析样品饲养生理性衰老果蝇30天后,体内丙二醛(MDA)、过氧化氢酶(CAT)和谷胱甘肽过氧化物酶(GSH-px)等过氧化指标测定,结果表明65%-75%分级醇沉金蝉花多糖在体外模型中具有显著的抗氧化活性,且具有一定的剂量依赖性,表明醇沉金蝉花多糖在制备抗氧化衰老药物方面具有良好的潜力。In order to detect the antioxidant activity of the polysaccharide product obtained by the invention, each graded polysaccharide obtained by the invention was added to the basal medium of Drosophila at a ratio of 1% (w/v), and fed with physiological senescent fruit Fly and hydrogen peroxide oxidative stress in Drosophila, respectively observe the effect of samples on the lifespan of Drosophila at different doses, and analyze the in vivo malondialdehyde (MDA), catalase (CAT) after feeding physiologically aging Drosophila for 30 days. and glutathione peroxidase (GSH-px) and other peroxidation indicators, the results show that 65%-75% graded alcohol-precipitated Cicada flower polysaccharide has significant antioxidant activity in the in vitro model, and has a certain dose Dependence, indicating that the alcohol-precipitated Cicada polysaccharide has a good potential in the preparation of anti-aging drugs.
3、本发明第三个方面涉及金蝉花多糖提取物与药学上可接受的辅料组成的药物组合物。3. The third aspect of the present invention relates to a pharmaceutical composition composed of the polysaccharide extract of Cicada japonica and pharmaceutically acceptable excipients.
金蝉花活性部位可单独或几种部位组合,再进一步与辅料组合,剂型包括:片剂、胶囊剂、丸剂、颗粒剂、混悬剂、滴丸、口服液体制剂等。The active parts of Cicada can be used alone or in combination of several parts, and further combined with auxiliary materials, and the dosage forms include: tablets, capsules, pills, granules, suspensions, drop pills, oral liquid preparations and the like.
本发明所述的载体或赋形剂包括药剂学常规应用的载体和赋形剂,例如溶剂、崩解剂、矫味剂、防腐剂、着色剂、粘合剂等。The carriers or excipients described in the present invention include conventional carriers and excipients in pharmacy, such as solvents, disintegrating agents, flavoring agents, preservatives, coloring agents, binders and the like.
下面的实施例和药理活性实验是对本发明的进一步详细说明,以下所列举的实施例不以任何方式构成限制。The following examples and pharmacological activity experiments are further detailed descriptions of the present invention, and the examples listed below are not intended to be limiting in any way.
本发明从金蝉花水提物中分离出具有高效抗氧化活性的小分子多糖,并通过多次醇沉去除部分蛋白质等杂质,且不同分子结构的金蝉花多糖得到有效分离,使目标多糖纯度相对较高,为研究出针对抗氧化活性的金蝉花多糖,提高多糖利用率。The invention separates small molecular polysaccharides with high-efficiency antioxidant activity from the water extract of Cicada japonica, and removes some impurities such as proteins through multiple alcohol precipitation, and the polysaccharides of different molecular structures are effectively separated, so that the target polysaccharide can be effectively separated. The purity is relatively high, in order to study the polysaccharide of Cicada flower for antioxidant activity and improve the utilization rate of polysaccharide.
附图说明Description of drawings
图1金蝉花多糖CP5延长了生理性衰老果蝇的寿命(n=100)。随机分为4组:空白对照组、金蝉花多糖高1%、中0.5%、低0.1%剂量组,每组100只。每日观察并记录果蝇的存活情况,每3天更换一次培养基,直至果蝇全部死亡。数据用Log-rank检验进行分析。Fig. 1 Cicada polysaccharide CP5 prolongs the lifespan of physiologically aging Drosophila (n=100). Randomly divided into 4 groups: blank control group, high 1%, medium 0.5% and low 0.1% dose groups of Cicada flower polysaccharide, with 100 animals in each group. The survival of the flies was observed and recorded daily, and the medium was changed every 3 days until all the flies died. Data were analyzed with the Log-rank test.
图2金蝉花CP4多糖能抑制果蝇双氧水氧化应激引起的损伤(n=100)。随机分为4组:空白对照组、金蝉花多糖高1%、中0.5%、低0.1%剂量组,每组100只。每日观察并记录果蝇的存活情况,每3天更换一次培养基,直至果蝇全部死亡。数据用Log-rank检验进行分析。Figure 2 Cicada cicada CP4 polysaccharide can inhibit the damage caused by oxidative stress of hydrogen peroxide in Drosophila (n=100). Randomly divided into 4 groups: blank control group, high 1%, medium 0.5% and low 0.1% dose groups of Cicada flower polysaccharide, with 100 animals in each group. The survival of the flies was observed and recorded daily, and the medium was changed every 3 days until all the flies died. Data were analyzed with the Log-rank test.
图3金蝉花多糖CP4对果蝇中抗氧化酶活性的影响。随机分为4组:空白对照组、金蝉花多糖高1%、中0.5%、低0.1%剂量组,每组100只。每3天更换一次培养基,饲喂第30天后测定果蝇体内MDA、GSH-PX含量和CAT酶活力。数据以平均值±SD表示。数据通过ANOVA分析,然后进行Dunnett's t-检验。与空白对照组相比,*P<0.05,**P<0.01,***P<0.001。(A)CP4处理降低了果蝇中丙二醛(MDA)的含量。(B)CP70-60处理显著增加了果蝇中过氧化氢酶(CAT)的含量。(C)CP4处理增强了果蝇中谷胱甘肽过氧化酶(GSH-px)的活性,雌果蝇均呈剂量依赖性,而(B)和(C)中雄果蝇的中剂量最为明显。Fig. 3 The effect of Cicada polysaccharide CP4 on the activity of antioxidant enzymes in Drosophila. Randomly divided into 4 groups: blank control group, high 1%, medium 0.5% and low 0.1% dose groups of Cicada flower polysaccharide, with 100 animals in each group. The medium was changed every 3 days, and the content of MDA, GSH-PX and CAT enzyme activity in Drosophila were measured after the 30th day of feeding. Data are presented as mean ± SD. Data were analyzed by ANOVA followed by Dunnett's t-test. Compared with blank control group, *P<0.05, **P<0.01, ***P<0.001. (A) CP4 treatment reduces malondialdehyde (MDA) levels in Drosophila. (B) CP70-60 treatment significantly increased catalase (CAT) levels in Drosophila. (C) CP4 treatment enhanced the activity of glutathione peroxidase (GSH-px) in Drosophila flies in a dose-dependent manner in both female flies, while the middle doses in (B) and (C) were most pronounced in male flies .
具体实施方式Detailed ways
实施例1 70%乙醇—分级醇沉多糖部位对生理性衰老果蝇的影响:Example 1 The effect of 70% ethanol-fractionated alcohol-precipitated polysaccharide fractions on physiological aging Drosophila:
(1)金蝉花70%乙醇—分级醇沉多糖部位(CP5)的制备:(1) Preparation of 70% ethanol-graded alcohol-precipitated polysaccharide fraction (CP5) of Cicada flower:
干燥金蝉花药材,粉碎过药典2号筛,按液料比5:1的石油醚浸提金蝉花粉末,进行脱脂处理,脱脂后的粉末于40℃烘干备用,石油醚在30℃下进行回收。称取金蝉花粉末50g,用500mL蒸馏水在90℃条件下,回流提取两次,每次2小时,提取液经减压浓缩后,加入3/7倍体积的95%乙醇,使乙醇终浓度达到30%,于4℃条件下,静置12小时。离心沉淀后的多糖加水复溶后,减压浓缩至无醇味,冷冻干燥,得到金蝉花粗多糖CP1组分。根据上清液剩余体积,继续加入1/6倍体积的无水乙醇,使乙醇终浓度达到40%,方法相同,冷冻干燥,得到40%乙醇—分级醇沉多糖部位(CP2)。依次使乙醇终浓度达到50%、60%、70%和80%,得到各个分级金蝉花多糖(CP3、CP4、CP5和CP6)和剩余水部位。其中多糖CP5组分即为金蝉花70%乙醇沉淀的多糖部位。Dried Cicada flower medicinal materials, crushed through the No. 2 sieve of the pharmacopoeia, and extracted the Cicada flower powder with petroleum ether with a liquid-material ratio of 5:1, and carried out degreasing treatment. recycling below. Weigh 50 g of Cicada flower powder and extract it twice with 500 mL of distilled water at 90°C for 2 hours each time. After the extract is concentrated under reduced pressure, add 3/7 times the volume of 95% ethanol to make the final concentration of ethanol. After reaching 30%, it was allowed to stand at 4°C for 12 hours. The polysaccharide after centrifugal precipitation is reconstituted with water, concentrated under reduced pressure until there is no alcohol smell, and freeze-dried to obtain the CP1 fraction of the crude polysaccharide of Cicada japonica. According to the remaining volume of the supernatant, continue to add 1/6 times the volume of absolute ethanol to make the final concentration of ethanol reach 40%. The method is the same, freeze-drying, and obtain 40% ethanol-fractionated alcohol-precipitated polysaccharide fraction (CP2). The final concentration of ethanol was sequentially made to reach 50%, 60%, 70% and 80% to obtain each graded Cicada flower polysaccharide (CP3, CP4, CP5 and CP6) and remaining water fractions. Among them, the polysaccharide CP5 component is the polysaccharide part precipitated by 70% ethanol of Cicada flower.
(2)果蝇的培养:(2) Cultivation of Drosophila:
果蝇,为野生型Oregon K黑腹果蝇,由江苏大学药学院提供。将果蝇安置在含有5mL培养基的50mL培养瓶中,在25℃,60±5%湿度,24h昼夜交替的生化培养箱(邦西仪器科技(上海)有限公司)中。果蝇培养基,为标准玉米粉琼脂培养基,由青岛海博生物科技有限公司(Qingdao,China;http://www.hopebiol.com/)购得,在室温、避光和干燥条件下保存。Drosophila, wild-type Oregon K melanogaster, was provided by the School of Pharmacy, Jiangsu University. Drosophila were placed in a 50 mL culture flask containing 5 mL of medium in a biochemical incubator (Bongxi Instrument Technology (Shanghai) Co., Ltd.) at 25°C, 60±5% humidity, and 24h day-night alternation. Drosophila medium, a standard corn meal agar medium, purchased from Qingdao Haibo Biotechnology Co., Ltd. (Qingdao, China; http://www.hopebiol.com/), stored at room temperature, protected from light and under dry conditions .
(3)CP5对生理性衰老果蝇的影响:(3) Effects of CP5 on physiologically aging Drosophila:
收集8h内羽化的雄性果蝇400只。随机分为4组:0%对照组和1%、0.5%、0.1%CP5处理的剂量组,每组各100只,分为4管,每管25只。对照组的果蝇饲喂基础培养基,CP5剂量组的果蝇分别以混有70%乙醇—分级醇沉多糖的培养基喂养。正常给药,每3天更换一次培养基。每两日观察并记录果蝇的存活情况,直至果蝇全部死亡,观察生存时间。绘制寿命曲线,并计算果蝇的平均寿命、半数死亡时间和最高寿命。最长寿命的计算方法是最长幸存10%的果蝇种群的平均寿命(图1)。400 male Drosophila flies that emerged within 8 hours were collected. Randomly divided into 4 groups: 0% control group and 1%, 0.5%, 0.1% CP5-treated dose groups, with 100 animals in each group, divided into 4 tubes, with 25 animals in each tube. Drosophila in the control group were fed with basal medium, while those in the CP5 dose group were fed with medium mixed with 70% ethanol-fractionated alcohol-precipitated polysaccharide. Dosing normally, with medium changes every 3 days. The survival of the fruit flies was observed and recorded every two days until all the fruit flies died, and the survival time was observed. Plot lifespan curves and calculate the average lifespan, half time to death, and maximum lifespan of the flies. The longest lifespan was calculated as the average lifespan of the longest surviving 10% of the Drosophila population (Figure 1).
表1用金蝉花多糖CP5饲喂生理性衰老果蝇的寿命参数Table 1 Lifespan parameters of physiologically aging Drosophila fed with Cicada polysaccharide CP5
注:最高寿命计算为每组中最长幸存的果蝇10%的平均寿命(与空白对照组相比,*P<0.05,**P<0.01,***P<0.001)。NOTE: Maximum lifespan was calculated as the mean lifespan of the longest surviving 10% of flies in each group (*P<0.05, **P<0.01, ***P<0.001 compared to blank control).
果蝇生理性衰老模型,可以直观地得出金蝉花多糖CP5各剂量延长果蝇的半数死亡时间、平均寿命和最高寿命。其中,中等剂量组效果最为显著,与对照组相比,可将果蝇半数死亡时间延长31.03%,平均寿命延长29.98%,最高寿命延长25.58%。说明CP5具有延缓果蝇寿命的功效(表1)。In the Drosophila physiological aging model, it can be intuitively concluded that each dose of the polysaccharide CP5 prolongs the half death time, average lifespan and maximum lifespan of Drosophila. Among them, the middle-dose group had the most significant effect. Compared with the control group, it could prolong the half-death time of fruit flies by 31.03%, the average lifespan by 29.98%, and the maximum lifespan by 25.58%. It shows that CP5 has the effect of prolonging the lifespan of Drosophila (Table 1).
实施例2金蝉花65%乙醇—分级醇沉多糖部位对H2O2氧化应激衰老果蝇的影响:Example 2 The effect of 65% ethanol-graded alcohol-precipitated polysaccharide fractions on H 2 O 2 oxidative stress aging Drosophila:
(1)金蝉花65%乙醇—分级醇沉多糖部位的制备:(1) Preparation of 65% ethanol-graded alcohol-precipitated polysaccharide part of Cicada flower:
干燥金蝉花药材,粉碎过药典2号筛,按液料比8:1的石油醚浸提金蝉花粉末,进行脱脂处理,脱脂后的粉末于40℃烘干备用,石油醚在30℃下进行回收。称取金蝉花粉末50g,用600mL蒸馏水在80℃条件下,回流提取两次,每次3小时,提取液经减压浓缩后,加入95%乙醇,使乙醇终浓度达到35%,于0℃条件下,静置24小时。离心沉淀后的多糖加水复溶后,减压浓缩至无醇味,冷冻干燥,得到金蝉花粗多糖CP1组分。根据上清液剩余体积,继续加入1/6倍体积的95%乙醇,使乙醇终浓度达到45%,方法相同,冷冻干燥,得到45%乙醇沉淀金蝉花多糖组分(CP2)。重复以上操作,依次使乙醇终浓度达到55%、65%、75%,得到各个分级金蝉花多糖(CP2、CP3、CP4、CP5)和剩余水部位。其中多糖CP4组分即为金蝉花65%乙醇—分级醇沉多糖部位。Dried Cicada flower medicinal materials, crushed through the No. 2 sieve of the pharmacopoeia, leached the Cicada flower powder with petroleum ether with a liquid-material ratio of 8:1, and carried out degreasing treatment. recycling below. Weigh 50 g of Cicada flower powder and extract it twice with 600 mL of distilled water at 80 °C for 3 hours each time. After the extract is concentrated under reduced pressure, 95% ethanol is added to make the final concentration of ethanol reach 35%. Under the condition of ℃, let stand for 24 hours. The polysaccharide after centrifugal precipitation is reconstituted with water, concentrated under reduced pressure until there is no alcohol smell, and freeze-dried to obtain the CP1 fraction of the crude polysaccharide of Cicada japonica. According to the remaining volume of the supernatant, continue to add 1/6 volume of 95% ethanol to make the final concentration of ethanol reach 45%. The method is the same, freeze-drying, and obtain 45% ethanol-precipitated Cicada flower polysaccharide fraction (CP2). The above operations were repeated to make the final concentration of ethanol reach 55%, 65%, and 75% in turn to obtain each graded Cicada flower polysaccharide (CP2, CP3, CP4, CP5) and remaining water fractions. Among them, the polysaccharide CP4 component is the 65% ethanol-graded alcohol-precipitated polysaccharide part of Cicada flower.
(2)金蝉花65%乙醇—分级醇沉多糖部位对H2O2氧化应激衰老果蝇的影响:(2) Effects of 65% ethanol-graded alcohol-precipitated polysaccharide fractions of Cicada officinalis on H 2 O 2 oxidative stress aging Drosophila:
收集8h内羽化的雄性果蝇400只。随机分为4组:对照组和1%、0.5%、0.1%CP4处理的剂量组,每组各100只,分为4管,每管25只。对照组的果蝇饲喂基础培养基,CP4剂量组的果蝇分别以补充有65%乙醇—分级醇沉多糖部位的培养基喂养。在正常给药第30天,移出果蝇,饥饿适应2h后,将果蝇转移至干净已灭菌的培养管中,管底部放一片圆形的滤纸,该纸片由含有6%葡萄糖的30%H2O2溶液浸润。400 male Drosophila flies that emerged within 8 hours were collected. Randomly divided into 4 groups: control group and 1%, 0.5%, 0.1% CP4 dose groups, 100 animals in each group, divided into 4 tubes, 25 animals in each tube. Drosophila in the control group were fed with basal medium, while those in the CP4 dose group were fed with medium supplemented with 65% ethanol-fractionated alcohol-precipitated polysaccharide fractions. On the 30th day of normal administration, the fruit flies were removed, and after starvation adaptation for 2 hours, the fruit flies were transferred to a clean and sterilized culture tube, and a piece of circular filter paper was placed at the bottom of the tube. % H2O2 solution infiltration.
记录每3h果蝇死亡数,直至所有果蝇死亡。绘制寿命曲线,并计算果蝇的平均寿命、半数死亡时间和最高寿命(图2)。The number of dead flies was recorded every 3 h until all flies died. Plot lifespan curves and calculate the mean lifespan, half time to death and maximum lifespan of the flies (Figure 2).
表2金蝉花CP4多糖对H2O2急性损伤果蝇寿命的影响(n=100)Table 2 The effect of Cicada cicada CP4 polysaccharide on the lifespan of Drosophila acutely injured by H 2 O 2 (n=100)
注:最大寿命计算为每组中最长幸存的果蝇10%的平均寿命(与空白对照组相比,*P<0.05,**P<0.01,***P<0.001。)NOTE: Maximum lifespan was calculated as the mean lifespan of the 10% longest surviving flies in each group (*P<0.05, **P<0.01, ***P<0.001 compared to blank control.)
由表2和图2可知,在H2O2急性氧化损伤中,给药组与模型组相比果蝇存活时间差异显著。金蝉花多糖CP4各剂量均可延长果蝇的半数死亡时间、平均寿命和最高寿命。其中中等剂量组效果最为显著,与对照组相比,可将果蝇半数死亡时间延长29.17%,平均寿命延长28.91%,最高寿命延长20.0%。It can be seen from Table 2 and Figure 2 that in the acute oxidative injury of H 2 O 2 , the survival time of Drosophila was significantly different between the administration group and the model group. Each dose of Cicada polysaccharide CP4 could prolong the half death time, average lifespan and maximum lifespan of Drosophila flies. Among them, the middle-dose group had the most significant effect. Compared with the control group, it could prolong the half death time of fruit flies by 29.17%, prolong the average lifespan by 28.91%, and prolong the maximum lifespan by 20.0%.
实施例3 75%乙醇—分级醇沉多糖对果蝇体内抗氧化指标的影响:Example 3 The effect of 75% ethanol-fractionated alcohol-precipitated polysaccharide on antioxidant indexes in Drosophila:
(1)75%乙醇—分级醇沉多糖(CP4)的制备:(1) Preparation of 75% ethanol-fractionated alcohol-precipitated polysaccharide (CP4):
干燥金蝉花药材,粉碎过药典2号筛,按液料比3:1的石油醚浸提金蝉花粉末,进行脱脂处理,脱脂后的粉末于40℃烘干备用,石油醚在30℃下进行回收。称取金蝉花粉末50g,用750mL蒸馏水在100℃条件下,回流提取三次,每次2小时,提取液经减压浓缩后,加入1/5倍体积的无水乙醇,使乙醇终浓度达到40%,于10℃条件下,静置48h。离心沉淀后的多糖加水复溶后,减压浓缩至无醇味,冷冻干燥,得到金蝉花粗多糖CP1组分。根据上清液剩余体积,继续加入1/6倍体积的无水乙醇,使乙醇终浓度达到50%,方法相同,冷冻干燥,得到50%乙醇沉淀金蝉花多糖组分(CP2)。重复以上操作,依次使乙醇终浓度达到65%、75%和85%,得到各个分级金蝉花多糖(CP3、CP4和CP5)和剩余水部位。其中多糖CP4组分即为金蝉花75%乙醇—分级醇沉多糖。Dried Cicada flower medicinal materials, crushed through the No. 2 sieve of the pharmacopoeia, extracted the Cicada flower powder with petroleum ether with a liquid-material ratio of 3:1, and carried out degreasing treatment. recycling below. Weigh 50 g of Cicada flower powder, and extract it with 750 mL of distilled water at 100 °C for three times under reflux for 2 hours each time. After the extract is concentrated under reduced pressure, add 1/5 times the volume of anhydrous ethanol to make the final ethanol concentration. 40% under the condition of 10 ℃, let stand for 48h. The polysaccharide after centrifugal precipitation is reconstituted with water, concentrated under reduced pressure until there is no alcohol smell, and freeze-dried to obtain the CP1 fraction of the crude polysaccharide of Cicada japonica. According to the remaining volume of the supernatant, continue to add 1/6 times the volume of absolute ethanol to make the final ethanol concentration reach 50%. The method is the same, freeze-drying, and obtain 50% ethanol-precipitated Cicada flower polysaccharide fraction (CP2). The above operations were repeated to make the final concentration of ethanol reach 65%, 75% and 85% in turn to obtain each graded Cicada flower polysaccharides (CP3, CP4 and CP5) and remaining water fractions. Among them, the polysaccharide CP4 component is 75% ethanol-graded alcohol precipitation polysaccharide of Cicada flower.
(2)CP4对果蝇体内抗氧化指标的影响:(2) Effects of CP4 on antioxidant indexes in Drosophila:
收集8h内羽化的雌雄果蝇720只。随机分为4组:对照组和1%、0.5%、0.1%CP4处理的剂量组,每组雌、雄果蝇各90只,每组分为3管,每管30只,每3天更换一次培养基。对照组的果蝇饲喂基础培养基,CP4剂量组的果蝇分别以补充有金蝉花75%乙醇—分级醇沉多糖的培养基喂养。分别在第10天、20天和30天,取每组雌、雄果蝇各1管。饥饿适应2h后,加生理盐水冰浴研磨,离心得果蝇组织匀浆。按照试剂盒说明操作,测定组织匀浆中蛋白含量、MDA含量、CAT活性和GSH-px的含量(图3)。720 male and female Drosophila eclosion within 8 hours were collected. Randomly divided into 4 groups: control group and 1%, 0.5%, 0.1% CP4-treated dose groups, 90 female and 90 male flies in each group, each group is divided into 3 tubes, 30 in each tube, replaced every 3 days a medium. Drosophila in the control group were fed with basal medium, and Drosophila in the CP4 dose group were fed with medium supplemented with 75% ethanol-fractionated alcohol-precipitated polysaccharide from Cicada flower. On the 10th day, 20th day and 30th day, respectively, take one tube of each group of female and male Drosophila. After starvation for 2 hours, add normal saline to grind in ice bath, and centrifuge to obtain Drosophila tissue homogenate. Follow the kit instructions to measure protein content, MDA content, CAT activity and GSH-px content in tissue homogenate (Figure 3).
表3金蝉花多糖CP4对果蝇抗氧化能力的影响Table 3 The effect of the polysaccharide CP4 of Cicada flower on the antioxidant capacity of Drosophila
注:与空白对照组相比,*P<0.05,**P<0.01,***P<0.001。Note: Compared with blank control group, *P<0.05, **P<0.01, ***P<0.001.
由表可知,喂饲30天金蝉花多糖CP4后,各剂量组果蝇体内的MDA含量与对照组比较明显下降(P<0.0001);随着多糖浓度的增加,各剂量组果蝇体内的,CAT酶活力和GSH-PX含量逐渐升高,且雌果蝇尤为突出,各剂量组与对照组比较差异有统计学意义(P<0.01或P<0.01)。It can be seen from the table that after 30 days of feeding with polysaccharide CP4, the content of MDA in the flies in each dose group was significantly lower than that in the control group (P<0.0001); , CAT enzyme activity and GSH-PX content gradually increased, especially in female Drosophila, and the difference between each dose group and the control group was statistically significant (P<0.01 or P<0.01).
实施例4金蝉花滴丸的制备The preparation of embodiment 4 Jinchanhua dripping pills
分别称取400g聚乙二醇4000,在水浴上熔化,再加入金蝉花70%乙醇—分级醇沉多糖450g冻干粉末,搅拌均匀,倾入保温管中,调节恒温装置,使药液在80~90℃下滴入冷却过的液体石蜡中(温度±4℃),滴完后,将药丸倾入滤纸上吸干石蜡油,再加入少量滑石粉,混匀,得金蝉花70%乙醇—分级醇沉多糖滴丸1000粒。Weigh 400g of polyethylene glycol 4000 respectively, melt it on a water bath, add 70% ethanol of Cicada flower - graded alcohol-precipitated polysaccharide 450g freeze-dried powder, stir evenly, pour it into a heat preservation tube, adjust the constant temperature device, and make the liquid medicine at Drop into the cooled liquid paraffin at 80-90°C (temperature ±4°C), after dripping, pour the pills onto the filter paper to absorb the paraffin oil, then add a small amount of talc powder and mix well to obtain 70% of Cicada flower. 1000 ethanol-graded alcohol-precipitated polysaccharide dropping pills.
实施例5金蝉花胶囊剂的制备The preparation of embodiment 5 Jinchanhua capsules
金蝉花70%乙醇—分级醇沉多糖冻干粉末1000g,与药用淀粉500g混合均匀,烘干,按每粒0.45g制成胶囊。1000g of lyophilized powder of 70% ethanol of Cicada flower - graded alcohol precipitation polysaccharide, mixed evenly with 500g of medicinal starch, dried, and made into capsules by 0.45g each.
实施例6金蝉花片剂的制备The preparation of embodiment 6 Cicada flower tablet
金蝉花70%乙醇—分级醇沉多糖冻干粉末1000g,淀粉500g,混合均匀,用适量乙醇制粒,经整粒机整粒,压片,每片0.35g。Cicada flower 70% ethanol - 1000g of freeze-dried powder of graded alcohol precipitation polysaccharide, 500g of starch, mixed evenly, granulated with an appropriate amount of ethanol, granulated by a granulator, and pressed into tablets, each 0.35g.
实施例7金蝉花颗粒剂的制备The preparation of embodiment 7 Jinchanhua granules
金蝉花70%乙醇—分级醇沉多糖冻干粉末1500g,淀粉1000g,糖粉400g,混合均匀,用适量乙醇制粒,干燥、整粒、分装即得。Cicada flower 70% ethanol - graded alcohol precipitation polysaccharide freeze-dried powder 1500g, starch 1000g, icing sugar 400g, mixed evenly, granulated with an appropriate amount of ethanol, dried, granulated and packaged.
Claims (7)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910328312.8A CN109985070A (en) | 2019-04-23 | 2019-04-23 | A kind of Cicada flower extract and its application in the preparation of antioxidant medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910328312.8A CN109985070A (en) | 2019-04-23 | 2019-04-23 | A kind of Cicada flower extract and its application in the preparation of antioxidant medicine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109985070A true CN109985070A (en) | 2019-07-09 |
Family
ID=67135042
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910328312.8A Pending CN109985070A (en) | 2019-04-23 | 2019-04-23 | A kind of Cicada flower extract and its application in the preparation of antioxidant medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109985070A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111150066A (en) * | 2020-02-19 | 2020-05-15 | 苟春虎 | Epidemic prevention immune peptide |
| CN112552424A (en) * | 2020-12-10 | 2021-03-26 | 浙江省林业科学研究院 | Cordyceps sobolifera sporophore polysaccharide and preparation and application thereof |
| CN115645511A (en) * | 2020-06-12 | 2023-01-31 | 青岛农业大学 | Application of biological agent in preparation of antibacterial and antiviral drugs |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103992416A (en) * | 2014-05-28 | 2014-08-20 | 江苏大学 | Isaria cosmopaltriae yasuda polysaccharide and applications thereof in preparing nerve-protective and anti-aging drug |
-
2019
- 2019-04-23 CN CN201910328312.8A patent/CN109985070A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103992416A (en) * | 2014-05-28 | 2014-08-20 | 江苏大学 | Isaria cosmopaltriae yasuda polysaccharide and applications thereof in preparing nerve-protective and anti-aging drug |
Non-Patent Citations (6)
| Title |
|---|
| DAMAGEOPEYEMI J. OLATUNJI等: ""Polysaccharides purified from Cordyceps cicadae protects PC12 cellsagainst glutamate-induced oxidative damage"", 《CARBOHYDRATE POLYMERS》 * |
| 封燕等: ""金蝉花多糖的抗氧化活性及结构分析"", 《食品科学》 * |
| 王吉标等: ""响应面分析法优化金蝉花多糖的提取工艺"", 《天然产物研究与开发》 * |
| 葛琦: ""金蝉花成分分析及多糖抗氧化活性研究"", 《江苏大学硕士论文》 * |
| 邵颖等: ""人工培育蝉花孢梗束分级多糖的抗氧化活性及对果蝇寿命的影响"", 《食品研究与开发》 * |
| 邵颖等: ""蝉花孢子粉分级多糖的体外抗氧化活性"", 《食品科技》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111150066A (en) * | 2020-02-19 | 2020-05-15 | 苟春虎 | Epidemic prevention immune peptide |
| CN115645511A (en) * | 2020-06-12 | 2023-01-31 | 青岛农业大学 | Application of biological agent in preparation of antibacterial and antiviral drugs |
| CN115645511B (en) * | 2020-06-12 | 2024-03-15 | 青岛农业大学 | Biological agent for treating diarrhea of pets |
| CN112552424A (en) * | 2020-12-10 | 2021-03-26 | 浙江省林业科学研究院 | Cordyceps sobolifera sporophore polysaccharide and preparation and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6381818B2 (en) | Composition comprising an extract or fraction of a genus Fox | |
| CN106573024A (en) | Composition for improving liver function, containing extract of dendropanax morbifera | |
| TWI300352B (en) | Water soluble extract from plant of solanum genus and the preparation process thereof, and pharmaceutical composition containing the water soluble extract | |
| CN103992416A (en) | Isaria cosmopaltriae yasuda polysaccharide and applications thereof in preparing nerve-protective and anti-aging drug | |
| CN109985070A (en) | A kind of Cicada flower extract and its application in the preparation of antioxidant medicine | |
| CN106474145B (en) | Application of the Polysaccharides from Leaves of Moringa oleifera in preparation prevention and treatment alcoholic liver injury drug and food | |
| KR20170055758A (en) | Anti inflammatory comprising plant extract | |
| CN103564495B (en) | Propolis and cordycepic hypha powder composition, as well as preparation and application thereof | |
| TWI554277B (en) | Pharmaceutical composition for preventing and treating nonalcoholic fatty liver disease | |
| CN1329038C (en) | Water-soluble extract of nightshade plant, its preparation method and its pharmaceutical composition | |
| CN107551001B (en) | A kind of traditional Chinese medicine compound for preventing and treating alcoholic liver injury and preparation method thereof | |
| CN107233366A (en) | A kind of leaf of Moringa granule and preparation method and application | |
| KR101529279B1 (en) | Liver cytoprotective composition comprising an extract of brassica juncea coss. and compounds isolated therefrom | |
| WO2006118314A1 (en) | Agent for suppressing accumulation of lipid in liver | |
| KR101110063B1 (en) | Anticancer composition | |
| CN103446358B (en) | Tibetan medicine Piper pulicatulum C. D C. Rhizoma Iridis Tectori antioxidant extract and its production and use | |
| CN109481481B (en) | Preparation method and application of chimonanthus salicifolius total flavone extract | |
| CN103655628A (en) | Propolis extract and application thereof | |
| JP7095872B2 (en) | Interleukin-33 production inhibitor and pharmaceuticals, quasi-drugs, cosmetics and food and drink compositions for the prevention, treatment or suppression of allergic diseases associated with an increase in interleukin-33. | |
| WO2021251920A1 (en) | Use of propolis obtained by special extraction method in liquid mixtures | |
| KR20210147247A (en) | A composition for immune enhancement comprising narrow-leaf erecta fig extract mixture | |
| TWI501771B (en) | Pharmaceutical composition for preventing and treating liver fibrosis | |
| JP2003252780A (en) | Apoptosis inducer | |
| CN101524485A (en) | Application of sorghum in preparing anticancer medicaments | |
| KR20140118531A (en) | Compositions Comprising Extract from Litchi chinensis Sonn. and Artemisiae Iwayomogii Herba. for Preventing, Improving or Treating Obesity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190709 |